SuperworthBoundless Bio market cap BOLD
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $53.7M
- Highest close in our data
- $251.7M
- May 2024
Boundless Bio is worth $53.7M at the close on Oct 23, 2026, at $2.36 a share.
That is up 64% over the last year.
Its highest close in our data was $251.7M in May 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $53.7M | $24.2M | $68.2M | +100% |
| 2025 | $26.9M | $22.6M | $59.8M | −53% |
| 2024 | $56.9M | $52.4M | $251.7M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Boundless Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| BOLDBoundless Bio | $53.7M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| Peer median | $73.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Boundless Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.